Wana Brands Poised to Serve Illinois #MedicalMarijuana Patients Via Exclusive Licensing Agreement with Grassroots Cannabis
CHICAGO - October 24, 2018 (Investorideas.com Newswire) Medical cannabis patients across Illinois will soon have access to the nation's most dependable infused edibles. Leading edibles producer Wana Brands has finalized an exclusive licensing agreement with Grassroots Cannabis, Illinois' largest medical cannabis company. The partnership will bring Wana Brands' consistent, top-quality medical cannabis products to Illinois dispensaries in the fourth quarter of 2018.
"Grassroots Cannabis is hands-down the most trusted provider of medical cannabis in Illinois. Its loyal patient base and a strong focus on compliance are why Wana Brands sought it out as a partner," said Nancy Whiteman, Founder & CEO of Wana Brands.
The agreement with Grassroots Cannabis marks another milestone in Wana Brands' continued expansion from its Colorado headquarters. The Company's consistent and potent medical marijuana products are also available in Arizona, Nevada and Oregon dispensaries, with Florida among the states imminently coming online. Wana Brands expects to expand into California, Maryland, Michigan, Ohio, Pennsylvania, Washington, and internationally in Canada through 2019. Wana Brands is the No. 1 infused cannabis brand in Colorado, selling more units and dollars than any other cannabis products company, according to an August 2018 report from point-of-sale tracking firm BDS Analytics.
"Illinois patients rely on Grassroots Cannabis for top-quality medical cannabis products," said Mitch Kahn, Co-Founder & CEO of Grassroots Cannabis. "This partnership with an internationally recognized company such as Wana Brands further cements our role as the state's leading medical cannabis provider."
Products coming to the Illinois market in Fall 2018 include Wana Brands' safe and reliable gummies that deliver precise dosing for patients. Wana Gummies feature standardized dosing of 10 milligrams of THC per piece and two flavors, Mango (Sativa) and Blueberry (Indica). All Wana products are naturally flavored, vegan and gluten-free.
"Wana Brands is known for innovative and dependable products because of our strict quality standards, and this extends across all markets," Whiteman noted. "The team at Grassroots Cannabis is equally dedicated, and we look forward to building on this partnership."
Grassroots Cannabis is the largest medical cannabis provider in Illinois, serving 24 percent of the state's patients. The company has grown exponentially since its establishment in 2014, when Illinois implemented the Compassionate Use of Medical Cannabis Pilot Program. It currently operates eight dispensaries across the state. Grassroots Cannabis has since expanded into Maryland, Nevada, North Dakota, Ohio and Pennsylvania, with applications pending in four additional states.
"The dominance of Wana Brands in Colorado and other legal cannabis markets is a testament to the company's focus on delivering only the highest quality, most consistent products," Kahn continued. "Grassroots Cannabis shares the same objectives as we grow our company."
The licensing agreement has been approved by the Illinois Department of Public Health (IDPH).
More than 44,000 patients have joined Illinois' Medical Cannabis Registry Program since it launched in September 2014, with numbers skyrocketing after Governor Bruce Rauner signed a measure Aug. 28 aimed at strengthening the state's fight in the ongoing opioid crisis, allowing doctors to prescribe medical marijuana instead of opioids to help patients with chronic pain, stemming from cancer or other medical issues. Qualifying medical conditions include HIV / AIDS, ALS, Alzheimer's disease, cancer, Crohn's disease, severe fibromyalgia, glaucoma, hepatitis C, lupus, multiple sclerosis, muscular dystrophy, Parkinson's disease, epilepsy, spinal cord disease / injury, traumatic brain injury and post-traumatic stress disorder (PTSD).
For more information or to schedule an interview, please contact Shawna McGregor / Grasslands at 917-971-7852 or email@example.com.
**Product images available upon request.**
Wana Brands: Enhance Your Life.
Named The Cannabist People's Choice Award Winner for Best Edible in January 2018, Wana Brands is the No. 1 cannabis-infused product company in Colorado, with more units and dollars sold than any other brand, according to a August 2018 BDS Analytics report. Wana leads the industry in quality, consistency and potency, featuring a full line of edibles, including market-leading gummies and WanaCapsXR, a family of extended-release cannabis capsules that provide symptom relief for up to 12 hours. Wana products are also available in Arizona, Oregon and Nevada, with new market entries in Illinois and Florida. Wana plans to enter into California, Maryland, Michigan, Ohio, Pennsylvania, Washington, and internationally in Canada in the coming year. For more information, visit WanaBrands.com. Follow Wana on Facebook, Instagram, LinkedIn and Twitter.
About Grassroots Cannabis
Greenhouse Compass Ventures LLC (dba Grassroots Cannabis) is a rapidly expanding medical cannabis grower and processor with facilities in Illinois, Maryland, Nevada, North Dakota, Ohio and Pennsylvania. The company has submitted license applications in Arkansas, Connecticut, Michigan and Virginia, and is pursuing additional markets. Executive management is composed of a group of highly skilled business leaders who possess the wide-ranging expertise needed to operate a successful, safe, secure and compliant medical cannabis organization. For more information, visit grassrootscannabis.com.
Grasslands: A Journalism-Minded Agency
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com